Qicong Luo

1.2k total citations
22 papers, 656 citations indexed

About

Qicong Luo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Qicong Luo has authored 22 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Qicong Luo's work include Wnt/β-catenin signaling in development and cancer (7 papers), Epigenetics and DNA Methylation (4 papers) and MicroRNA in disease regulation (4 papers). Qicong Luo is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (7 papers), Epigenetics and DNA Methylation (4 papers) and MicroRNA in disease regulation (4 papers). Qicong Luo collaborates with scholars based in China, Singapore and United States. Qicong Luo's co-authors include Wangyu Cai, Qi Luo, Boan Li, Guodong Ye, Yang Meng, Qingfeng Liu, Guodong Ye, Zhengjie Huang, Weifeng Huang and Chunpeng Wan and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Journal of Cell Science.

In The Last Decade

Qicong Luo

22 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qicong Luo China 13 464 261 158 92 64 22 656
Junwei Song China 14 547 1.2× 287 1.1× 137 0.9× 81 0.9× 64 1.0× 18 712
Zejun Fang China 15 381 0.8× 196 0.8× 169 1.1× 77 0.8× 58 0.9× 27 548
Zu-yun Li China 17 520 1.1× 453 1.7× 172 1.1× 109 1.2× 62 1.0× 27 756
Umar Raza China 14 407 0.9× 296 1.1× 153 1.0× 88 1.0× 37 0.6× 21 627
Ufuk Degirmenci Singapore 7 480 1.0× 222 0.9× 128 0.8× 57 0.6× 75 1.2× 7 653
Lu Yue China 17 627 1.4× 234 0.9× 227 1.4× 119 1.3× 66 1.0× 34 866
Anais Del Curatolo Malaysia 6 404 0.9× 158 0.6× 155 1.0× 83 0.9× 63 1.0× 7 546
Yosuke Endo‐Sakamoto Japan 17 456 1.0× 203 0.8× 173 1.1× 72 0.8× 35 0.5× 37 634
Xianqiu Wu China 15 483 1.0× 223 0.9× 193 1.2× 115 1.3× 61 1.0× 26 740
Jia Min Loo Singapore 9 461 1.0× 292 1.1× 176 1.1× 51 0.6× 39 0.6× 14 689

Countries citing papers authored by Qicong Luo

Since Specialization
Citations

This map shows the geographic impact of Qicong Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qicong Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qicong Luo more than expected).

Fields of papers citing papers by Qicong Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qicong Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qicong Luo. The network helps show where Qicong Luo may publish in the future.

Co-authorship network of co-authors of Qicong Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Qicong Luo. A scholar is included among the top collaborators of Qicong Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qicong Luo. Qicong Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Yangfan, Yizhen Pang, Kaili Fu, et al.. (2025). FAP-targeted radioligand therapy with 68Ga/177Lu-DOTA-2P(FAPI)2 enhance immunogenicity and synergize with PD-L1 inhibitors for improved antitumor efficacy. Journal for ImmunoTherapy of Cancer. 13(1). e010212–e010212. 11 indexed citations
3.
Chen, Jianhao, Yizhen Pang, Yangfan Zhou, et al.. (2024). Development of [177Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 52(1). 247–259. 2 indexed citations
4.
Luo, Qicong, Lingyun Lin, Huiyu Hu, et al.. (2023). Apatinib remodels the immunosuppressive tumor ecosystem of gastric cancer enhancing anti-PD-1 immunotherapy. Cell Reports. 42(5). 112437–112437. 22 indexed citations
5.
Zhang, Rui, Guojun Geng, Xiaolei Zhu, et al.. (2022). An NF-κB/OVOL2 circuit regulates glucose import and cell survival in non-small cell lung cancer. Cell Communication and Signaling. 20(1). 40–40. 9 indexed citations
6.
Xia, Rongmu, Guojun Geng, Xiuyi Yu, et al.. (2021). LINC01140 promotes the progression and tumor immune escape in lung cancer by sponging multiple microRNAs. Journal for ImmunoTherapy of Cancer. 9(8). e002746–e002746. 42 indexed citations
7.
8.
Cai, Wangyu, Lingyun Lin, Lin Wang, et al.. (2019). Inhibition of Bcl6b promotes gastric cancer by amplifying inflammation in mice. Cell Communication and Signaling. 17(1). 72–72. 11 indexed citations
9.
Cai, Chengfu, Guodong Ye, Dong‐Yan Shen, et al.. (2018). Chibby suppresses aerobic glycolysis and proliferation of nasopharyngeal carcinoma via the Wnt/β-catenin-Lin28/let7-PDK1 cascade. Journal of Experimental & Clinical Cancer Research. 37(1). 104–104. 43 indexed citations
10.
Wu, Qiu-Wan, et al.. (2018). Extracellular matrix protein 1 recruits moesin to facilitate invadopodia formation and breast cancer metastasis. Cancer Letters. 437. 44–55. 27 indexed citations
11.
Wang, Tao, Jingjing Hou, Qicong Luo, et al.. (2018). miR-29b negatively regulates MMP2 to impact gastric cancer development by suppress gastric cancer cell migration and tumor growth. Journal of Cancer. 9(20). 3776–3786. 35 indexed citations
12.
Cai, Wangyu, Gang Chen, Qicong Luo, et al.. (2017). PMP22 Regulates Self-Renewal and Chemoresistance of Gastric Cancer Cells. Molecular Cancer Therapeutics. 16(6). 1187–1198. 37 indexed citations
14.
Xu, Hao, et al.. (2016). Establishment and characterization of an expanding-type gastric cancer cell line by Ming's classification. Oncology Reports. 36(5). 3030–3036. 8 indexed citations
15.
Chen, Jiajia, Wangyu Cai, Xuewen Liu, et al.. (2015). Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion. PLoS ONE. 10(5). e0126890–e0126890. 31 indexed citations
16.
Geng, Guojun, Ning Li, Yanjun Mi, et al.. (2015). Prognostic value of SATB2 expression in patients with esophageal squamous cell carcinoma.. PubMed. 8(1). 423–31. 17 indexed citations
17.
Huang, Weifeng, Chunpeng Wan, Qicong Luo, et al.. (2014). Genistein-Inhibited Cancer Stem Cell-Like Properties and Reduced Chemoresistance of Gastric Cancer. International Journal of Molecular Sciences. 15(3). 3432–3443. 77 indexed citations
18.
Cai, Wangyu, Qicong Luo, Qiu-Wan Wu, et al.. (2013). Wnt/β-catenin pathway represses let-7 microRNAs expression via transactivation of Lin28 to augment breast cancer stem cell expansion. Journal of Cell Science. 126(Pt 13). 2877–89. 111 indexed citations
19.
Chen, Jiakun, Qicong Luo, Yuanyang Yuan, et al.. (2010). Pygo2 Associates with MLL2 Histone Methyltransferase and GCN5 Histone Acetyltransferase Complexes To Augment Wnt Target Gene Expression and Breast Cancer Stem-Like Cell Expansion. Molecular and Cellular Biology. 30(24). 5621–5635. 64 indexed citations
20.
Tao, Ping, Donghui Xu, Shuibin Lin, et al.. (2007). Abnormal expression, highly efficient detection and novel truncations of midkine in human tumors, cancers and cell lines. Cancer Letters. 253(1). 60–67. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026